$58.00
10.8523.01%
Last update: Nov 5, 7:59 PM
Eton Pharmaceuticals Inc
ETONNASDAQ
The average analyst price target for Eton Pharmaceuticals is $56, 3.4% below the current price. Of 4 analysts, 4 rate it Buy. Targets range from $10 to $70. The latest change came on Aug 14, 2026, when Canaccord Genuity raised its price target on Eton Pharmaceuticals from $60 to $68 and kept a Buy rating.
Price Target Range — 10 Quarters
Analyst Consensus — 4 Analysts
Rating Trend — Last 9 Months
